Agonists to the A3 adenosine receptor induce G-CSF production via NF-κB activation: A new class of myeloprotective agents

Experimental Hematology

Volumn 30, Issue 12, 2002, Pages 1390-1398

  Bar Yehuda, Sara ^a   Madi, Lea ^b   Barak, Dana ^c   Mittelman, Moshe ^a   Ardon, Eti ^b   Ochaion, Avivit ^b   Cohn, Shira ^b   Fishman, Pnina ^a,b,d  

^a TEL AVIV UNIVERSITY   (Israel)

^b Can Fite BioPharma Ltd   (Israel)

^c BAR ILAN UNIVERSITY   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; ADENOSINE RECEPTOR STIMULATING AGENT; AGAR; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; ARTICLE; BLOOD CELL COUNT; COLONY FORMATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; LEUKOCYTE; MALE; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SPLEEN CELL; WESTERN BLOTTING;

ANIMALS; BONE MARROW CELLS; BONE MARROW DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GRANULOCYTE COLONY-STIMULATING FACTOR; LIGANDS; MALE; MICE; MICE, INBRED ICR; MYELOID CELLS; NF-KAPPA B; PROTECTIVE AGENTS; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; SIGNAL TRANSDUCTION; SPLEEN; UP-REGULATION;

EID: 18744393077     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00962-1     Document Type: Article

References (35)

1. Brandt S.J., Peters W.P., Atwater S.K.et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med. 318:1988;869.
2. Terashi K., Oka M., Ohdo S.et al. Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor on neutrophils in cancer patients. Antimicrob Agents Chemother. 43:1999;21.
3. Takatani H., Soda H., Fukuda M.et al. Levels of recombinant human granulocyte colony-stimulating factor in serum are inversely correlated with circulating ANC. Antimicrob Agents Chemother. 40:1996;988.
4. Dunn S.M., Coles L.S., Lang R.K., Gerondakis S., Vadas M.A., Shannon M.F. Requirement for nuclear factor (NF)-κ B p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter. Blood. 83:1994;2469.
5. Joyce D., Albanese C., Steer J., Fu M., Bouzahzah B., Pestel R.G. NF-κB and cell-cycle regulation. the cyclin connection Cytokine Growth Factor Rev. 12:2000;73.
6. Datta S.R., Brunet A., Greenberg M.E. Cellular survival. a play in three Akts Genes Dev. 13:1999;2905.
7. Farina M.C., Requena L., Domin M., Soriano M.L., Estevez L., Barat A. Histopathology of cutaneous reaction to granulocyte colony-stimulating factor. another pseudomalignancy J Cutan Pathol. 25:1998;559.
8. Rusthoven J., Bramwel V.I., Stephenson B. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial systemic treatment disease site group. Cancer Prev Control. 2:1998;179.
9. Furet I., Closson V., Madelaine I., Faure P. G-CSF (granulocyte colony-stimulating factor). follow-up and use in a French university hospital Can J Hosp Pharm. 48:1995;90.
10. Lyman G.H., Kudere N.R., Greene J., Balducci L. The economies of febrile neutropenia. implications for the use of colony-stimulating factors Eur J Cancer. 34:1998;1857.
11. Fishman P., Bar-Yehuda S., Farbstein T., Barer F., Ohana G. Adenosine acts as a chemoprotective agent by stimulating G-CSF production. A role for A1&A3 adenosine receptors J Cell Physiol. 183:2000;393.
12. Fishman P., Bar-Yehuda S., Barer F., Madi L., Multani A.S., Pathak S. The A3 adenosine receptor as a new target for cancer therapy and chemoprotection. Exp Cell Res. 269:2001;230.
13. Bar-Yehuda S., Barer F., Volfsson L., Fishman P. Resistance of muscle to tumor metastases. a role for A3 adenosine receptor agonists Neoplasia. 3:2001;125.
14. Abbracchio M.P. P1 and P2 receptors in cell growth and differentiation. Drug Dev Res. 38:1996;393.
15. Fishman P., Bar-Yehuda S., Wagman L. Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth. possible explanation for the rarity of metastases in muscle Cancer Res. 58:1998;3181.
16. Ohana G., Bar-Yehuda S., Barer F., Fishman P. Differential effect of adenosine on tumor and normal cell growth. focus on the A3 adenosine receptor J Cell Physiol. 186:2001;19.
17. Poulsen S.A., Quinn R.J. Adenosine receptors. new opportunities for future drugs Bioorg Med Chem. 6:1998;619.
18. Olah M.E., Stiles G.L. The role of receptor structure in determining adenosine receptor activity. Pharmacol Ther. 85:2000;55.
19. Gutkind J.S. Cell growth control by G protein-coupled receptors. from signal transduction to signal integration Oncogene. 17:1998;1331.
20. Pluznik D.H., Sachs L. The induction of colonies of normal "must" cells by substance in conditioned medium. Exp Cell Res. 43:1996;553.
21. Burgess A.W., Camakaris J., Metcalf D. Purification and properties of colony stimulating factor from mouse lung-conditioned medium. J Biol Chem. 252:1977;1998.
22. Kim H.O., Ji X.D., Siddiqi S.M., Olah M.E., Stiles G.L., Jacobson K.A. 2-Substitution of N6-benzyladenosine-5′-uronamidase enhances selectivity for A3 adenosine receptors. J Med Chem. 37:1994;3614.
23. Jacobson K.A., Kong-Chul Y., An-Hu L. A3 adenosine receptors. protective vs damaging effects identified using novel agonists and antagonists Drug Dev Res. 45:1998;113.
24. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., Donner D.B. NF-κB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature. 401:1999;82.
25. Shannon M.F., Coles L.S., Fielke R.K., Goodall G.J., Lagnado C.A., Vadas M.A. Three essential promoter elements mediate tumor necrosis factor and interleukin-1 activation of the granulocyte colony-stimulating factor gene. Growth Factors. 7:1992;181.
26. Jonsson A.S., Palmblad J.E. Effects of ethanol on NF-κB activation, production of myeloid growth factors, and adhesive events in human endothelial cells. J Infect Dis. 184:2001;761.
27. Gao Z., Li B.S., Day Y.J., Linden J. A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol Pharmacol. 59:2001;76.
28. Sunil V.R., Connor A.J., Lavnikova N., Gardner C.R., Laskin J.D., Laskin D.L. Acute endotoxemia prolongs the survival of rat lung neutrophils in response to 12-O-tetradecanoyl-phorbol 13-acetate. J Cell Physiol. 190:2002;382.
29. Fishman P., Bar-Yehuda S., Ohana G.et al. Adenosine acts as an inhibitor of lymphoma cell growth. a major role for the A3 adenosine receptor Eur J Cancer. 36:2000;1452.
30. Fishman P., Madi L., Bar-Yehuda S., Barer F., Del Valle L., Kahalili K. Evidence for the involvement of wnt signaling pathway in IB-MECA mediated suppression of melanoma cells. Oncogene. 21:2002;4060.
31. Von Lubitz D.K., Simpson K.L., Lin R.C. Right thing at a wrong time? Adenosine A3 receptors and cerebroprotection in stroke. Ann NY Acad Sci 939:2001;85.
32. Liu G.S., Richards S.C., Olsson R.A., Mullane K.H., Walsh R.S., Downey J.M. Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res 28:1994;1057.
33. Shneyvays V., Mamedova L., Zinman T., Jacobson K., Shainberg A. Activation of A3 adenosine receptor protects against doxorubicin-induced cardiotoxicity. J Mol Cell Cardiol. 33:2001;1249.
34. Jacobson K.A., Xie R., Young L., Chang L., Liang B.T. A novel pharmacological approach to treating cardiac ischemia. Binary conjugates of A1 and A3 adenosine receptor agonists. J Biol Chem 275:2000;30272.
35. Bowlin T.L., Brocherding D.R., Edwards C.K. 3rd, Mc Whinney C.D. Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-α production in vitro and in vivo. Cell Mol Biol (Noisy-le-grand). 43:1997;345.